SIMCERE PHARMACEUTICAL GRP LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 2096 for the last semiannual is 3.49 B HKD, and it's 8.74% lower compared to the previous semiannual. The net income of H2 23 is -1.69 B HKD.